Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 4 of 4 for “"Rifampicin-resistant TB"”.

  1. Population pharmacokinetic modelling to optimise treatment for children with Rifampicin-resistant TB and HIV

    The global burden of rifampicin- and/or multidrug-resistant (RR/MDR) -TB, i.e. Mycobacterium tuberculosis resistant to rifampicin and/or isoniazid is increasing, especially in settings with high HIV prevalence. Optimising the prevention and treatment of RR/MDR-TB in children in such settings is …

    cape-town Repository record for Population pharmacokinetic modelling to optimise treatment for children with Rifampicin-resistant TB and HIV (opens in a new tab)

  2. Screening rare filamentous actinobacteria for novel antimycobacterial compounds

    Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (M.tb). According to the World Health Organization (WHO), TB is one of the top 10 causes of death worldwide and the leading cause of death from a single infectious agent. There were an estimated 1.2 million TB deaths …

    cape-town Repository record for Screening rare filamentous actinobacteria for novel antimycobacterial compounds (opens in a new tab)

  3. Prevalence of drug-resistant tuberculosis and associated risk factors among patients in the Northern Region of South Africa

    Background: Drug-resistant TB is a major global health threat, driving the ongoing TB epidemic and increasing morbidity and mortality worldwide. Currently, national tuberculosis (TB) control programmes are challenged by the emergence of drug resistance to more anti-TB drugs resulting in multi-drug …

    venda Repository record for Prevalence of drug-resistant tuberculosis and associated risk factors among patients in the Northern Region of South Africa (opens in a new tab)

  4. The Epidemiology and Evolution of Rifampicin Mono Resistant Tuberculosis in Khayelitsha, Cape Town, South Africa

    … to the World Health Organization Global TB report 2018, rifampicin monoresistant tuberculosis (RMR-TB) comprises 22% and 38% of all rifampicin-resistant TB (RR-TB) globally, and within South Africa, respectively. National surveys from South Africa show an increasing proportion of RMR-TB

    cape-town Repository record for The Epidemiology and Evolution of Rifampicin Mono Resistant Tuberculosis in Khayelitsha, Cape Town, South Africa (opens in a new tab)